An integrated bioinformatical analysis to evaluate the role of KIF4A as a prognostic biomarker for breast cancer

References

• SiegelRLMillerKDJemalACancer statistics, 2017CA Cancer J Clin201767173028055103
   PubMed Web of Science ®Google Scholar
• MillerKDSiegelRLLinCCCancer treatment and survivorship statistics, 2016CA Cancer J Clin201666427128927253694
   PubMed Web of Science ®Google Scholar
• PatersonRPhillipsKAGenetic testing in women with breast cancer: implications for treatmentExpert Rev Anticancer Ther20171711991100228853307
   PubMed Web of Science ®Google Scholar
• KatanodaKMatsudaTFive-year relative survival rate of breast cancer in the USA, Europe and JapanJpn J Clin Oncol201444661124864272
   PubMed Web of Science ®Google Scholar
• ChangHYNuytenDSSneddonJBRobustness, scalability, and integration of a wound-response gene expression signature in predicting breast cancer survivalProc Natl Acad Sci U S A2005102103738374315701700
   PubMed Web of Science ®Google Scholar
• PuhallaSLDavidsonNEBreast cancer: the 21-gene recurrence score – biology remains at the forefrontNat Rev Clin Oncol201613847047227296295
   PubMed Web of Science ®Google Scholar
• van’t VeerLJDaiHvan de VijverMJGene expression profiling predicts clinical outcome of breast cancerNature2002415687153053611823860
   PubMed Web of Science ®Google Scholar
• MazumdarMSundareshanSMisteliTHuman chromokinesin KIF4A functions in chromosome condensation and segregationJ Cell Biol2004166561362015326200
   PubMed Web of Science ®Google Scholar
• KurasawaYEarnshawWCMochizukiYDohmaeNTodokoroKEssential roles of KIF4 and its binding partner PRC1 in organized central spindle midzone formationEMBO J200423163237324815297875
   PubMed Web of Science ®Google Scholar
• ZhuCJiangWCell cycle-dependent translocation of PRC1 on the spindle by Kif4 is essential for midzone formation and cytokinesisProc Natl Acad Sci U S A2005102234334815625105
   PubMed Web of Science ®Google Scholar
• HuCKCoughlinMFieldCMMitchisonTJKIF4 regulates midzone length during cytokinesisCurr Biol2011211081582421565503
   PubMed Web of Science ®Google Scholar
• TaniwakiMTakanoAIshikawaNActivation of KIF4A as a prognostic biomarker and therapeutic target for lung cancerClin Cancer Res20071322 Pt 16624663118006763
   PubMed Web of Science ®Google Scholar
• ZhangLHuangQLouJA novel PHD-finger protein 14/KIF4A complex overexpressed in lung cancer is involved in cell mitosis regulation and tumorigenesisOncotarget2017812196841969828160558
   PubMedGoogle Scholar
• WangHLuCLiQThe role of Kif4A in doxorubicin-induced apoptosis in breast cancer cellsMol Cells2014371181281825377255
   PubMed Web of Science ®Google Scholar
• NarayanGBourdonVChagantiSGene dosage alterations revealed by cDNA microarray analysis in cervical cancer: identification of candidate amplified and overexpressed genesGenes Chromosomes Cancer200746437338417243165
   PubMed Web of Science ®Google Scholar
• HouGDongCDongZUpregulate KIF4A enhances proliferation, invasion of hepatocellular carcinoma and indicates poor prognosis across human cancer typesSci Rep201771414828646197
   PubMed Web of Science ®Google Scholar
• MinakawaYKasamatsuAKoikeHKinesin family member 4A: a potential predictor for progression of human oral cancerPLoS One2013812e8595124386490
   PubMed Web of Science ®Google Scholar
• ZhangYLiuSQuDKif4A mediate the accumulation and reeducation of THP-1 derived macrophages via regulation of CCL2-CCR2 expression in crosstalking with OSCCSci Rep201771222628533507
   PubMed Web of Science ®Google Scholar
• GaoJSaiNWangCOverexpression of chromokinesin KIF4 inhibits proliferation of human gastric carcinoma cells both in vitro and in vivoTumour Biol2011321536120711700
   PubMedGoogle Scholar
• WuGZhouLKhidrLA novel role of the chromokinesin Kif4A in DNA damage responseCell Cycle20087132013202018604178
   PubMed Web of Science ®Google Scholar
• SchickelRBoyerinasBParkSMPeterMEMicroRNAs: key players in the immune system, differentiation, tumorigenesis and cell deathOncogene200827455959597418836476
   PubMed Web of Science ®Google Scholar
• ChenXWuBXuZDownregulation of miR-133b predict progression and poor prognosis in patients with urothelial carcinoma of bladderCancer Med2016581856186227292588
   PubMed Web of Science ®Google Scholar
• ChenXNWangKFXuZQMiR-133b regulates bladder cancer cell proliferation and apoptosis by targeting Bcl-w and Akt1Cancer Cell Int2014147025414595
   PubMed Web of Science ®Google Scholar
• BartelDPMicroRNAs: genomics, biogenesis, mechanism, and functionCell2004116228129714744438
   PubMed Web of Science ®Google Scholar
• FaraziTAHoellJIMorozovPTuschlTMicroRNAs in human cancerAdv Exp Med Biol201377412023377965
   PubMed Web of Science ®Google Scholar
• WangKChenXZhanYmiR-335 inhibits the proliferation and invasion of clear cell renal cell carcinoma cells through direct suppression of BCL-WTumour Biol20153696875688225846734
   PubMedGoogle Scholar
• YatesLANorburyCJGilbertRJThe long and short of microRNACell2013153351651923622238
   PubMed Web of Science ®Google Scholar
• DassowHAignerAMicroRNAs (miRNAs) in colorectal cancer: from aberrant expression towards therapyCurr Pharm Des20131971242125223570052
   PubMed Web of Science ®Google Scholar
• ZhangBPanXCobbGPAndersonTAmicroRNAs as oncogenes and tumor suppressorsDev Biol2007302111216989803
   PubMed Web of Science ®Google Scholar
• BarbatoSSolainiGFabbriMMicroRNAs in oncogenesis and tumor suppressionInt Rev Cell Mol Biol201733322926828729026
   PubMed Web of Science ®Google Scholar
• FangYZhangLLiZLiYHuangCLuXMicroRNAs in DNA damage response, carcinogenesis, and chemoresistanceInt Rev Cell Mol Biol201733314928729023
   PubMed Web of Science ®Google Scholar
• LeeGYHavertyPMLiLComparative oncogenomics identifies PSMB4 and SHMT2 as potential cancer driver genesCancer Res201474113114312624755469
   PubMed Web of Science ®Google Scholar
• TomczakKCzerwinskaPWiznerowiczMThe Cancer Genome Atlas (TCGA): an immeasurable source of knowledgeContemp Oncol (Pozn)2015191AA68A7725691825
   PubMedGoogle Scholar
• DesmedtCPietteFLoiSStrong time dependence of the 76-gene prognostic signature for node-negative breast cancer patients in the TRANSBIG multicenter independent validation seriesClin Cancer Res200713113207321417545524
   PubMed Web of Science ®Google Scholar
• SmedsJMillerLDBjohleJGene profile and response to treatmentAnn Oncol200516Suppl 219520215668270
   PubMed Web of Science ®Google Scholar
• WangYKlijnJGZhangYGene-expression profiles to predict distant metastasis of lymph-node-negative primary breast cancerLancet2005365946067167915721472
   PubMed Web of Science ®Google Scholar
• IvshinaAVGeorgeJSenkoOGenetic reclassification of histologic grade delineates new clinical subtypes of breast cancerCancer Res20066621102921030117079448
   PubMed Web of Science ®Google Scholar
• van de VijverMJHeYDvan’t VeerLJA gene-expression signature as a predictor of survival in breast cancerN Engl J Med2002347251999200912490681
   PubMed Web of Science ®Google Scholar
• HennessyBTGonzalez-AnguloAMStemke-HaleKCharacterization of a naturally occurring breast cancer subset enriched in epithelial-to-mesenchymal transition and stem cell characteristicsCancer Res200969104116412419435916
   PubMed Web of Science ®Google Scholar
• MuranenTAGrecoDFagerholmRBreast tumors from CHEK2 1100delC-mutation carriers: genomic landscape and clinical implicationsBreast Cancer Res2011135R9021542898
   PubMed Web of Science ®Google Scholar
• EssermanLJBerryDACheangMCChemotherapy response and recurrence-free survival in neoadjuvant breast cancer depends on biomarker profiles: results from the I-SPY 1 TRIAL (CALGB 150007/150012; ACRIN 6657)Breast Cancer Res Treat201213231049106222198468
   PubMed Web of Science ®Google Scholar
• HatzisCPusztaiLValeroVA genomic predictor of response and survival following taxane-anthracycline chemotherapy for invasive breast cancerJAMA2011305181873188121558518
   PubMed Web of Science ®Google Scholar
• AzimHAJrBroheeSPeccatoriFABiology of breast cancer during pregnancy using genomic profilingEndocr Relat Cancer201421454555424825746
   PubMed Web of Science ®Google Scholar
• JezequelPLoussouarnDGuerin-CharbonnelCGene-expression molecular subtyping of triple-negative breast cancer tumours: importance of immune responseBreast Cancer Res2015174325887482
   PubMed Web of Science ®Google Scholar
• BuffaFMCampsCWinchesterLmicroRNA-associated progression pathways and potential therapeutic targets identified by integrated mRNA and microRNA expression profiling in breast cancerCancer Res201171175635564521737487
   PubMed Web of Science ®Google Scholar
• SubramanianATamayoPMoothaVKGene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profilesProc Natl Acad Sci U S A200510243155451555016199517
   PubMed Web of Science ®Google Scholar
• SorlieTTibshiraniRParkerJRepeated observation of breast tumor subtypes in independent gene expression data setsProc Natl Acad Sci U S A2003100148418842312829800
   PubMed Web of Science ®Google Scholar
• SorlieTWangYXiaoCDistinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platformsBMC Genomics2006712716729877
   PubMed Web of Science ®Google Scholar
• GoldhirschAWoodWCCoatesASStrategies for subtypes – dealing with the diversity of breast cancer: highlights of the St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2011Ann Oncol20112281736174721709140
   PubMed Web of Science ®Google Scholar
• BuysSSSandbachJFGammonAA study of over 35,000 women with breast cancer tested with a 25-gene panel of hereditary cancer genesCancer2017123101721173028085182
   PubMed Web of Science ®Google Scholar
• LiGGuoXTangLAnalysis of BRCA1/2 mutation spectrum and prevalence in unselected Chinese breast cancer patients by next-generation sequencingJ Cancer Res Clin Oncol2017143102011202428664449
   PubMed Web of Science ®Google Scholar
• CybulskiCCarrot-ZhangJKluzniakWGermline RECQL mutations are associated with breast cancer susceptibilityNat Genet201547664364625915596
   PubMed Web of Science ®Google Scholar
• BorysovSIGranicAPadmanabhanJWalczakCEPotterHAlzheimer Aβ disrupts the mitotic spindle and directly inhibits mitotic microtubule motorsCell Cycle20111091397141021566458
   PubMed Web of Science ®Google Scholar
• MidorikawaRTakeiYHirokawaNKIF4 motor regulates activity-dependent neuronal survival by suppressing PARP-1 enzymatic activityCell2006125237138316630823
   PubMed Web of Science ®Google Scholar
• DongYLiuYJiangALiRYinMWangYMicroRNA-335 suppresses the proliferation, migration, and invasion of breast cancer cells by targeting EphA4Mol Cell Biochem20184391–29510428795314
   PubMed Web of Science ®Google Scholar
• ShuMZhouYZhuWMicroRNA 335 is required for differentiation of malignant glioma cells induced by activation of cAMP/protein kinase A pathwayMol Pharmacol201281329229822172575
   PubMed Web of Science ®Google Scholar
• TavazoieSFAlarconCOskarssonTEndogenous human microRNAs that suppress breast cancer metastasisNature2008451717514715218185580
   PubMed Web of Science ®Google Scholar
• GaoYZengFWuJYMiR-335 inhibits migration of breast cancer cells through targeting oncoprotein c-MetTumour Biol20153642875288325492484
   PubMedGoogle Scholar
• WangHLiMZhangREffect of miR-335 upregulation on the apoptosis and invasion of lung cancer cell A549 and H1299Tumour Biol20133453101310923740614
   PubMedGoogle Scholar
• GaoLYangYXuHMiR-335 functions as a tumor suppressor in pancreatic cancer by targeting OCT4Tumour Biol20143588309831824859837
   PubMedGoogle Scholar
• LiHZhuHZhouYLong non-coding RNA MSTO2P promotes the proliferation and colony formation in gastric cancer by indirectly regulating miR-335 expressionTumour Biol2017396 1010428317705506
   Google Scholar
• YanZXiongYXuWIdentification of hsa-miR-335 as a prognostic signature in gastric cancerPLoS One201277e4003722802949
   PubMed Web of Science ®Google Scholar
• SorrentinoALiuCGAddarioAPeschleCScambiaGFerliniCRole of microRNAs in drug-resistant ovarian cancer cellsGynecol Oncol2008111347848618823650
   PubMed Web of Science ®Google Scholar
• XiongSWLinTXXuKWMicroRNA-335 acts as a candidate tumor suppressor in prostate cancerPathol Oncol Res201319352953723456549
   PubMed Web of Science ®Google Scholar
• ShuMZhengXWuSTargeting oncogenic miR-335 inhibits growth and invasion of malignant astrocytoma cellsMol Cancer2011105921592405
   PubMed Web of Science ®Google Scholar
• ShiLJiangDSunGmiR-335 promotes cell proliferation by directly targeting Rb1 in meningiomasJ Neurooncol2012110215516222886530
   PubMed Web of Science ®Google Scholar
• PngKJYoshidaMZhangXHMicroRNA-335 inhibits tumor reinitiation and is silenced through genetic and epigenetic mechanisms in human breast cancerGenes Dev201125322623121289068
   PubMed Web of Science ®Google Scholar
• HeynHEngelmannMSchreekSMicroRNA miR-335 is crucial for the BRCA1 regulatory cascade in breast cancer developmentInt J Cancer2011129122797280621618216
   PubMed Web of Science ®Google Scholar
• MengYZouQLiuTCaiXHuangYPanJmicroRNA-335 inhibits proliferation, cell-cycle progression, colony formation, and invasion via targeting PAX6 in breast cancer cellsMol Med Rep201511137938525323813
   PubMed Web of Science ®Google Scholar